New York Presbyterian Hospital — New York, New York

New York Presbyterian Hospital is a clinical research site located in New York, New York, United States 10065-4870.

Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

New York Presbyterian Hospital has participated in 111 clinical trials with 17 currently active.

Therapeutic areas: Beta-Thalassemia, Graft Versus Host Disease, Ulcerative Colitis.

Sponsors: Celgene, Mesoblast, Inc., Millennium Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian Hospital?

New York Presbyterian Hospital has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian Hospital conducted?

New York Presbyterian Hospital has 111 clinical trials on record, with 17 currently active. Their work covers Beta-Thalassemia, Graft Versus Host Disease, Ulcerative Colitis.

Is New York Presbyterian Hospital accredited by Crixeo Clinical Trials?

New York Presbyterian Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Presbyterian Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.